Found: 9
Select item for more details and to access through your institution.
Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non‐valvular atrial fibrillation and type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 9, p. 2107, doi. 10.1111/dom.13787
- By:
- Publication type:
- Article
Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective.
- Published in:
- Journal of Market Access & Health Policy, 2019, v. 7, n. 1, p. 1, doi. 10.1080/20016689.2018.1564506
- By:
- Publication type:
- Article
Targeting VEGF-A in myeloid cells enhances natural killer cell responses to chemotherapy and ameliorates cachexia.
- Published in:
- Nature Communications, 2016, v. 7, n. 8, p. 12528, doi. 10.1038/ncomms12528
- By:
- Publication type:
- Article
Effectiveness and safety of rivaroxaban vs. warfarin in patients with non‐valvular atrial fibrillation and heart failure.
- Published in:
- ESC Heart Failure, 2019, v. 6, n. 1, p. 10, doi. 10.1002/ehf2.12365
- By:
- Publication type:
- Article
Agreement between coding schemas used to identify bleeding‐related hospitalizations in claims analyses of nonvalvular atrial fibrillation patients.
- Published in:
- Clinical Cardiology, 2018, v. 41, n. 1, p. 119, doi. 10.1002/clc.22861
- By:
- Publication type:
- Article
Patient Preferences for Nonvitamin K Antagonist Oral Anticoagulants in Stroke Prevention: A Multicountry Discrete Choice Experiment.
- Published in:
- Cardiology Research & Practice, 2019, p. 1, doi. 10.1155/2019/5719624
- By:
- Publication type:
- Article
Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 2, p. 196, doi. 10.1002/phar.2213
- By:
- Publication type:
- Article
Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Rivaroxaban's Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2019, v. 25, p. 1, doi. 10.1177/1076029619868535
- By:
- Publication type:
- Article